“Conditions categorised as functional disorders such as functional dyspepsia, irritable bowel syndrome (IBS), diarrhoea and constipation exhibit a direct correlation with stress levels,” he says.

Cases where the cause of pain cannot be accurately identified despite various methods, such as gastroscopy, are classified as ‘functional dyspepsia.’ Functional dyspepsia is a common digestive ...

Functional dyspepsia or nonulcer dyspepsia, and nonerosive reflux disease (NERD) or endoscopy-negative reflux disease, are common reasons for referral to a gastroenterologist. Although there is ...

The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of ...

Poop can be green because of dietary choices, illness or infection, and certain medications, among other reasons. Find out ...

Ginger, known for its digestive benefits, may also improve blood pressure, cholesterol, and blood sugar control. However, ...

Her clinical and research focus includes patients with disorders of gut-brain interaction such as irritable bowel syndrome ...

Background and Aim: Functional dyspepsia (FD) is a common condition seen in primary gastroenterology practice. The present study was conducted to compare the clinical effectiveness of mosapride ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...

KarXT — now with the brand name Cobenfy— is expected to be available in October with a list price of about $22,500 annually.

You might even recall 2002, which began with a win but then descended into hell, 1-4 and 2-5, before Chad Pennington fell out ...

Xanomeline and trospium chloride is a first-in-class medication that selectively targets the M1 and M4 receptors without blocking D2 receptors.